JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4976
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
| $6K | ﹤0.01% |
108
-900
| -89% | -$47.6K |
2013 Q2
28 quarters
|
|
4977
FTAI Aviation
FTAI
$17.2B
| $6K | ﹤0.01% |
553
+38
| +7% | +$348 |
2019 Q2
4 quarters
|
|
|
IFN
4978
Aberdeen India Fund
IFN
$454M
| $6K | ﹤0.01% |
371
| – | – |
2018 Q4
6 quarters
|
|
4979
State Street SPDR S&P Capital Markets ETF
KCE
$512M
| $6K | ﹤0.01% |
+100
| New | +$5.26K |
2020 Q2
0 quarters
|
|
4980
NatWest
NWG
$69.9B
| $6K | ﹤0.01% |
1,707
-465,131
| -100% | -$1.45M |
2014 Q2
24 quarters
|
|
4981
PLDT
PHI
$3.79B
| $6K | ﹤0.01% |
246
-14,101
| -98% | -$335K |
2013 Q2
28 quarters
|
|
4982
ProShares Short Russell2000
RWM
$155M
| $6K | ﹤0.01% |
164
-739
| -82% | -$30.2K |
2019 Q1
5 quarters
|
|
4983
Star Group
SGU
$423M
| $6K | ﹤0.01% |
712
-589
| -45% | -$4.64K |
2019 Q1
5 quarters
|
|
4984
ProShares UltraShort Russell2000
TWM
$59M
| $6K | ﹤0.01% |
29
-29
| -50% | -$7.95K |
2020 Q1
1 quarter
|
|
|
FFNW
4985
DELISTED
First Financial Northwest, Inc
FFNW
| $6K | ﹤0.01% |
669
-12,825
| -95% | -$119K |
2016 Q4
14 quarters
|
|
|
AUMN
4986
DELISTED
Golden Minerals Company
AUMN
| $6K | ﹤0.01% |
603
| – | – |
2013 Q2
28 quarters
|
|
|
AVGR
4987
DELISTED
Avinger, Inc. Common Stock
AVGR
| $6K | ﹤0.01% |
+67
| New | +$7.59K |
2020 Q2
0 quarters
|
|
|
MLVF
4988
DELISTED
Malvern Bancorp, Inc.
MLVF
| $6K | ﹤0.01% |
523
-12,602
| -96% | -$149K |
2017 Q4
10 quarters
|
|
|
NAVB
4989
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $6K | ﹤0.01% |
1,450
+150
| +12% | +$287 |
2018 Q2
8 quarters
|
|
4990
ClearPoint Neuro
CLPT
$332M
| $5K | ﹤0.01% |
1,508
+8
| +0.5% | +$30 |
2019 Q3
3 quarters
|
|
4991
WisdomTree International Equity Fund
DWM
$654M
| $5K | ﹤0.01% |
117
+95
| +432% | +$4.03K |
2015 Q4
18 quarters
|
|
4992
FLEX LNG
FLNG
$1.69B
| $5K | ﹤0.01% |
+1,037
| New | +$5.09K |
2020 Q2
0 quarters
|
|
|
IMOS
4993
ChipMOS TECHNOLOGIES
IMOS
$2.9B
| $5K | ﹤0.01% |
+225
| New | +$4.61K |
2020 Q2
0 quarters
|
|
4994
Lineage Cell Therapeutics
LCTX
$235M
| $5K | ﹤0.01% |
5,536
-173,310
| -97% | -$153K |
2017 Q4
10 quarters
|
|
4995
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$906M
| $5K | ﹤0.01% |
62
-5
| -7% | -$413 |
2016 Q4
14 quarters
|
|
4996
McCormick & Company Voting
MKC.V
$12.4B
| $5K | ﹤0.01% |
+52
| New | +$4.29K |
2020 Q2
0 quarters
|
|
4997
PUT
Precigen
PGEN
$3.06B
| $5K | ﹤0.01% |
+1,000
| New | +$3.4K |
2020 Q2
0 quarters
|
|
4998
Smart Sand
SND
$226M
| $5K | ﹤0.01% |
5,113
-1,803
| -26% | -$1.71K |
2017 Q4
10 quarters
|
|
4999
Vanguard Russell 3000 ETF
VTHR
$4.83B
| $5K | ﹤0.01% |
+37
| New | +$4.88K |
2020 Q2
0 quarters
|
|
5000
Woori Financial
WF
$18.5B
| $5K | ﹤0.01% |
234
| – | – |
2015 Q4
18 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.